A technology guide to assessing liver safety with microphysiological systems

https://cn-bio.com/resource/a-technology-guide-to-assessing-liver-safety-with-microphysiological-systems/?utm_campaign=263069939-TOX-3rd%20Party%20Marketing%20Activities&utm_source=ppc&utm_medium=AZO-newsletter&utm_content=dili-guide Drug-induced liver injury remains one of the most significant safety challenges in drug development. This technology guide explores how liver microphysiological systems help de-risk safety assessment, investigate DILI mechanisms, and generate human-relevant insight. Includes practical implementation considerations and emerging regulatory perspectives.